Zhang Pengpeng, Happersett Laura, Ravindranath Bosky, Zelefsky Michael, Mageras Gig, Hunt Margie
Department of Medical Physics, Memorial Sloan-Kettering Cancer Center, New York, New York 10065.
Med Phys. 2016 May;43(5):2024. doi: 10.1118/1.4944737.
Robust detection of implanted fiducials is essential for monitoring intrafractional motion during hypofractionated treatment. The authors developed a plan optimization strategy to ensure clear visibility of implanted fiducials and facilitate 3D localization during volumetric modulated arc therapy (VMAT).
Periodic kilovoltage (kV) images were acquired at 20° gantry intervals and paired with simultaneously acquired 4.4° short arc megavoltage digital tomosynthesis (MV-DTS) to localize three fiducials during VMAT delivery for hypofractionated prostate cancer treatment. Beginning with the original optimized plan, control point segments where fiducials were consistently blocked by multileaf collimator (MLC) within each 4.4° MV-DTS interval were first identified. For each segment, MLC apertures were edited to expose the fiducial that led to the least increase in the cost function. Subsequently, MLC apertures of all control points not involved with fiducial visualization were reoptimized to compensate for plan quality losses and match the original dose-volume histogram. MV dose for each MV-DTS was also kept above 0.4 MU to ensure acceptable image quality. Different imaging (gantry) intervals and visibility margins around fiducials were also evaluated.
Fiducials were consistently blocked by the MLC for, on average, 36% of the imaging control points for five hypofractionated prostate VMAT plans but properly exposed after reoptimization. Reoptimization resulted in negligible dosimetric differences compared with original plans and outperformed simple aperture editing: on average, PTV D98 recovered from 87% to 94% of prescription, and PTV dose homogeneity improved from 9% to 7%. Without violating plan objectives and compromising delivery efficiency, the highest imaging frequency and largest margin that can be achieved are a 10° gantry interval, and 15 mm, respectively.
VMAT plans can be made to accommodate MV-kV imaging of fiducials. Fiducial visualization rate and workflow efficiency are significantly improved with an automatic modification and reoptimization approach.
在大分割治疗期间,可靠地检测植入的基准标记对于监测分次内运动至关重要。作者开发了一种计划优化策略,以确保植入基准标记的清晰可见性,并在容积调强弧形治疗(VMAT)期间便于三维定位。
在容积调强弧形治疗期间,以20°的机架角度间隔采集周期性千伏(kV)图像,并与同时采集的4.4°短弧兆伏数字断层合成(MV-DTS)配对,以定位大分割前列腺癌治疗的三个基准标记。从原始优化计划开始,首先识别在每个4.4°MV-DTS间隔内基准标记被多叶准直器(MLC)持续遮挡的控制点段。对于每个段,编辑MLC孔径以暴露导致成本函数增加最少的基准标记。随后,对所有与基准标记可视化无关的控制点的MLC孔径进行重新优化,以补偿计划质量损失并匹配原始剂量体积直方图。每个MV-DTS的MV剂量也保持在0.4 MU以上,以确保可接受的图像质量。还评估了不同的成像(机架)间隔和基准标记周围的可见性边缘。
对于五个大分割前列腺VMAT计划,平均有36%的成像控制点,基准标记被MLC持续遮挡,但重新优化后能正确暴露。与原始计划相比,重新优化导致的剂量差异可忽略不计,并且优于简单的孔径编辑:平均而言,计划靶体积(PTV)的D98从处方剂量的87%恢复到94%,PTV剂量均匀性从9%提高到7%。在不违反计划目标和不影响交付效率的情况下,可实现的最高成像频率和最大边缘分别为10°的机架角度间隔和15毫米。
可以制定VMAT计划以适应基准标记的MV-kV成像。通过自动修改和重新优化方法,基准标记的可视化率和工作流程效率得到显著提高。